Skip to main content

Cutaneous Squamous Cell Carcinoma: Managing Advanced Disease in the Era of Immunotherapy

This live web event has ended. Thank you for attending.

0 of 9 Sessions Available

  • SEP
    12
    September 12, 2019
    Thu 7:00 PM EDT 1H
    Closed
    • The avatar for the contributor named Emily Stamell Ruiz, MD, MPH. Emily Stamell Ruiz, MD, MPH
  • NOV
    13
    November 13, 2019
    Wed 12:00 PM EST 1H
    Closed
    • The avatar for the contributor named Ann Silk, MD, MS . Ann Silk, MD, MS
  • JUN
    24
    June 24, 2020
    Wed 6:00 PM EDT 1H
    Closed
    • The avatar for the contributor named Emily Stamell Ruiz, MD, MPH. Emily Stamell Ruiz, MD, MPH
  • SEP
    23
    September 23, 2020
    Wed 12:30 PM EDT 1H
    Closed
  • SEP
    29
    September 29, 2020
    Tue 9:00 AM EDT 1H
    Closed
  • OCT
    29
    October 29, 2020
    Thu 11:45 AM EDT 1H
    Closed
  • DEC
    10
    December 10, 2020
    Thu 12:15 PM CST 1H
    Closed
  • JAN
    20
    January 20, 2021
    Wed 8:00 AM EST 1H
    Closed
  • MAR
    05
    March 05, 2021
    Fri 12:15 PM EST 1H
    Closed

Contributors

  • Emily Stamell Ruiz, MD, MPH

    Director, Dana‐Farber/Brigham and Women's High‐Risk Skin Cancer Clinic
    Associate Physician
    Dana‐Farber/Brigham and Women's Cancer Center
    Instructor in Dermatology
    Harvard Medical School
    Boston, MA

    Emily Stamell Ruiz, MD, MPH is Director of the Dana-Farber/Brigham and Women’s High-Risk Skin Cancer Clinic, an Associate Physician at the Mohs and Dermatologic Surgery Center at Dana-Farber/Brigham and Women’s Cancer Center, and an Instructor in Dermatology at Harvard Medical School. Dr. Ruiz received her undergraduate degree from Duke University, her medical degree from New York University School of Medicine, and her Master of Public Health degree from Harvard School of Public Health.

    Dr. Ruiz completed an internship in internal medicine at New York University School of Medicine, a dermatology residency at Albert Einstein College of Medicine, and a fellowship in micrographic surgery and dermatologic oncology at Brigham and Women’s Hospital. Dr. Ruiz’s research focuses on the burden of skin cancer through health services research and nonmelanoma skin cancer outcomes studies.

  • Ann Silk, MD, MS

    Medical Oncologist
    Dana-Farber Cancer Institute
    Boston, MA

    Ann W. Silk, MD, MS is a medical oncologist at Dana‐Farber Cancer Institute, where she specializes in the care of patients with advanced skin cancers, including squamous cell carcinoma, Merkel cell carcinoma, basal cell carcinoma, and melanoma. She conducts clinical trials using immuno-therapeutics, such as immune checkpoint inhibitors, cytokine therapy, and oncolytic viral therapy.

    Dr. Silk received her medical doctorate and master’s degree in clinical research at the University of Pittsburgh in 2008. She completed a clinical fellowship in hematology and oncology at the University of Michigan in 2014. She joined the faculty at Dana-Farber Cancer Institute in 2019.

0 of 9 Sessions Available

This live web event has ended.